Vaccines don't usually make it into presidential debates; a few weeks ago, however, the Republican presidential candidates got into a heated debate over the HPV vaccine and whether it should be mandated for girls entering the 6th grade.
Personally, I'm not a fan of political candidates' attempts to influence public health decisions, especially when some of the "facts" thrown around during that debate have no basis in science. However, the squabbling of those politicians did remind me that we, as parents, need to be well informed and knowledgeable about the HPV vaccine.
The HPV vaccine is in fact the first vaccine ever introduced to help prevent cancer. Its primary goal is to reduce the number of cases of cervical cancer in women.
There are currently two brands of the vaccine licensed for use in the United States: Gardasil and Cervavix, which were first introduced in 2006. Gardasil is, by far, the most frequently used because it covers more strains of the HPV than does Cervavix, including the most common types that cause cervical cancer and genital warts.
To date, over 35 million doses have been administered, and these have had an excellent safety record. The vaccine, which is given as three separate injections over si months, with the doses spaced about two months apart, is most effective if all three doses are received before the first-ever sexual contact.
Typical side effects are swelling and redness at the site of injection. Another possible side effect might be syncope (passing out); however, health officials don't know whether the vaccine is the actual cause of this. One reason this debate is still going on is that the main population receiving the vaccine--preteen and teen girls--might be particularly prone to fainting when they are getting a shot. In any case, patients must be observed for 15 minutes after the injection is administered and again when they stand up.
The American Academy of Pediatrics recommends that girls start the vaccine when they have their checkups at ages 11 or 12 years. Why this young? As was mentioned above, to be most effective, the vaccine's three doses must be given to girls before they ever have sex and, sadly, a significant number of girls have had sex by age 15.
Besides 11- or 12-year-old girls, other candidates for HPV include females ages 11 to 26. (The vaccine's effectiveness--how well it works--is still being studied in women over 26 years of age.)
More recently, a third group was approved for the vaccination: males ages 9 to 26 years. HPV vaccine can prevent genital warts in males, and can help decrease the spread of HPV to women.
I want to stress again that the primary objective of the HPV vaccine is to reduce the number of cases of deadly cervical cancer in women. For this reason, I don't want the crucial good accomplished by the vaccine to be overshadowed by the fact that HPV is a sexually transmitted disease.
I am a huge fan of sexual abstinence in teenagers and encourage teens and parents to have ongoing discussions about abstinence, especially at home. Studies have shown repeatedly that talking to teens about safe sex does not increase their promiscuity or risk-taking behaviors, but instead can help protect them. And, until we achieve a 100-percent abstinence rate in teens, we need to do all we can to keep them safe.
Again, we mustn't let the fact that HPV is sexually transmitted distract us from its true worth, or prevent us from giving this vaccine to our loved ones. If someone offered you a vaccine that would prevent breast cancer from striking your child years later, wouldn't you take advantage of it?

